SEC Form 4 · accession 0001104659-17-000985
Voyager Therapeutics, Inc. · VYGR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jane Henderson
Officer — Sr. V.P. & CFO
Period of report
Jan 3, 2017
Accepted (ET)
Jan 5, 2017 · 5:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001640266
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $11.97 | Jan 3, 2017 | A | 214,000 | A | — | Jan 3, 2027 | Common Stock | 214,000 | 214,000 | D |
Explanation of responses
- F1These stock options were issued pursuant to the Voyager Therapeutics, Inc. 2015 Stock Option and Incentive Plan. 53,500 of the shares of common stock underlying the options will vest on 1/1/2018 and the remainder will vest in 36 equal monthly installments thereafter, subject to continued service.